The trial is intended to study to what extent a programme offering regulated access to cannabis may improve knowledge of the substance and its associated issues and concerns and may help reduce the health and social risks that drug consumption usually entails.
The open trial is centred on the ‘Cannabinotheque’, a single secure source authorised to provide regulated cannabis access on an association model. The point of sale will be established in the municipality of Vernier, a principal partner of the ChanGE Association, which is responsible for conducting and overseeing this pilot trial.